Wockhardt re-opens Indian CB sector

Pharma company brings first convertible since elections.
September 19, 2004

Mid-cap pharmaceuticals company Wockhardt demonstrated the new pricing reality for Indian issuers on Friday (September 17) with a $100 million deal via JPMorgan.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media